RA
VMD icon

Raffles Associates’s Viemed Healthcare VMD Stock Holding History

Raffles Associates’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6M Sell
403,691
-10,000
-2% -$99K 3.92% 9
2026
Q1 		$3.81M Sell
413,691
-4,000
-1% -$33.3K 3.31% 11
2025
Q4 		$3.1M Hold
417,691
– – 2.33% 15
2025
Q3 		$2.84M Buy
417,691
+15,000
+4% +$102K 2.64% 12
2025
Q2 		$2.78M Hold
402,691
– – 2.9% 11
2025
Q1 		$2.93M Hold
402,691
– – 3.57% 9
2024
Q4 		$3.23M Hold
402,691
– – 3.48% 9
2024
Q3 		$2.95M Buy
402,691
+40,000
+11% +$286K 3.03% 11
2024
Q2 		$2.38M Buy
362,691
+15,000
+4% +$113K 2.68% 12
2024
Q1 		$3.28M Hold
347,691
– – 3.81% 11
2023
Q4 		$2.73M Buy
347,691
+34,313
+11% +$249K 3.45% 9
2023
Q3 		$2.11M Hold
313,378
– – 2.79% 12
2023
Q2 		$3.06M Sell
313,378
-4,040
-1% -$41K 4.12% 7
2023
Q1 		$3.07M Buy
317,418
+15,000
+5% +$131K 4.18% 8
2022
Q4 		$2.29M Sell
302,418
-15,000
-5% -$102K 2.68% 10
2022
Q3 		$1.91M Buy
317,418
+10,000
+3% +$64.2K 2.03% 13
2022
Q2 		$1.65M Sell
307,418
-109,100
-26% -$588K 1.8% 15
2022
Q1 		$2.07M Buy
416,518
+45,000
+12% +$209K 2.13% 12
2021
Q4 		$1.94M Sell
371,518
-30,000
-7% -$167K 1.86% 12
2021
Q3 		$2.23M Sell
401,518
-25,000
-6% -$163K 2.06% 12
2021
Q2 		$3.05M Buy
426,518
+95,000
+29% +$823K 2.59% 13
2021
Q1 		$3.35M Buy
331,518
+10,000
+3% +$94.1K 3.41% 9
2020
Q4 		$2.5M Hold
321,518
– – 2.9% 10
2020
Q3 		$2.78M Sell
321,518
-200,000
-38% -$2.02M 4.72% 8
2020
Q2 		$5.01M Sell
521,518
-380,782
-42% -$2.96M 8.16% 3
2020
Q1 		$4.24M Buy
902,300
+10,000
+1% +$49.6K 7.73% 5
2019
Q4 		$5.58M Sell
892,300
-13,800
-2% -$95.7K 5.37% 7
2019
Q3 		$6.25M Buy
+906,100
New +$6.04M 5.96% 7

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Raffles Associates's VMD Position: Q2 2026 in Review

Raffles Associates reduced its Viemed Healthcare (VMD) stake by 2.4% in Q2 2026, selling an estimated $99K and leaving 403,691 shares worth $4.6M. The position accounts for 3.92% of the portfolio, ranked #9.

Raffles Associates first reported a position in VMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $6.25M in Q3 2019. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Raffles Associates held 403,691 shares of Viemed Healthcare worth $4.6M as of Q2 2026.
  • Raffles Associates sold 10,000 Viemed Healthcare shares in Q2 2026, an estimated $99K.
  • Viemed Healthcare made up 3.92% of Raffles Associates's portfolio in Q2 2026, its #9 holding.
  • Raffles Associates first reported a position in Viemed Healthcare in Q3 2019 and has held it in 28 quarters since.
  • Raffles Associates's Viemed Healthcare position peaked at $6.25M in Q3 2019.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Raffles Associates's 13F filing for Q2 2026, filed 14 Aug 2026.